InMed Pharmaceuticals Inc. Quarterly Depreciation in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
InMed Pharmaceuticals Inc. quarterly/annual Depreciation history and growth rate from Q3 2019 to Q3 2024.
  • InMed Pharmaceuticals Inc. Depreciation for the quarter ending September 30, 2024 was $13.6K, a 1.83% decline year-over-year.
  • InMed Pharmaceuticals Inc. annual Depreciation for 2024 was $47.7K, a 20.5% increase from 2023.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $13.6K -$253 -1.83% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q4 2023 $14.2K +$6.19K +76.8% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 $13.8K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q4 2022 $8.06K Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2020 $21.4K +$14.2K +197% Jul 1, 2020 Sep 30, 2020 10-Q 2020-12-17
Q3 2019 $7.18K Jul 1, 2019 Sep 30, 2019 10-Q 2020-12-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.